Announcements Trials

Browse Landscape

Phase

Status

Recruiting 2 Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 51 Neoplasms 34 Colorectal Neoplasms 23 Lung Neoplasms 17 Prostatic Neoplasms 16 Melanoma 15 Neoplastic Cells, Circulating 13 Pancreatic Neoplasms 11 Multiple Myeloma 11 Uterine Cervical Neoplasms 10 Ovarian Neoplasms 10 Carcinoma, Non-Small-Cell Lung 8 Papillomavirus Infections 7 Neoplasm Metastasis 7 Leukemia, Myeloid, Acute 7 Colonic Neoplasms 7 Lymphoma, Follicular 6 Lymphoma 6 Hematologic Neoplasms 6 Uveal Melanoma 5 Sarcoma 5 Head and Neck Neoplasms 5 Glioma 5 Uterine Cervical Dysplasia 4 Urinary Bladder Neoplasms 4 Rectal Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Glioblastoma 4 Disease 4 COVID-19 4

Interventions

Cyclophosphamide 56 Etoposide 40 Filgrastim 37 Carboplatin 34 Vincristine 30 Doxorubicin 30 Melphalan 27 Topotecan 25 Isotretinoin 24 Peripheral Blood Stem Cell Transplantation 23 Granulocyte Colony-Stimulating Factor 22 Cisplatin 21 Irinotecan 20 sargramostim 18 Temozolomide 17 humanized 3F8 anti-GD2 monoclonal antibody 15 Radiotherapy 15 3-Iodobenzylguanidine 13 Granulocyte-Macrophage Colony-Stimulating Factor 11 Busulfan 11 dinutuximab 10 Interleukin-2 9 aldesleukin 8 Thiotepa 8 Ifosfamide 8 etoposide phosphate 7 Mesna 7 Vorinostat 6 Stem Cell Transplantation 6 Polymerase Chain Reaction 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Neuroblastoma × Blood Specimen Collection × Clear all

NCT02864563 2023-12-01

PHRCNB07

Institut Curie

Phase NA Completed

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡